Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Baeten, Jared M, Prof, Donnell, Deborah, PhD, Mugo, Nelly R, MBChB, Ndase, Patrick, MBChB, Thomas, Katherine K, MS, Campbell, James D, MD, Wangisi, Jonathan, MBChB, Tappero, Jordan W, MD, Bukusi, Elizabeth A, MBChB, Cohen, Craig R, Prof, Katabira, Elly, Prof, Ronald, Allan, Prof, Tumwesigye, Elioda, MBChB, Were, Edwin, MBChB, Fife, Kenneth H, Prof, Kiarie, James, MBChB, Farquhar, Carey, Prof, John-Stewart, Grace, Prof, Kidoguchi, Lara, MPH, Coombs, Robert W, Prof, Hendrix, Craig, Prof, Marzinke, Mark A, PhD, Frenkel, Lisa, Prof, Haberer, Jessica E, MD, Bangsberg, David, Prof, Celum, Connie, Prof
Published in The Lancet infectious diseases (01.11.2014)
Published in The Lancet infectious diseases (01.11.2014)
Get full text
Journal Article